KMTS

Kestra Medical Technologies, Ltd. (KMTS) operates in the healthcare sector and is classified within the medical instruments & supplies industry. With a market capitalization of $1.42B, the company has significant scale, alongside revenue of $74.26M and a workforce of 330 employees. The financial health of KMTS presents several challenges. The company's profitability is heavily impaired, with operating and profit margins registering at -140.7% and -178.0%, respectively. Net income (TTM) stands at -$138,788,000, indicating significant losses. Returns on equity (-126.4%) and assets (-44.0%) are also negative, suggesting that KMTS is not generating sufficient returns from its investments. The balance sheet shows a relatively modest debt level of $44.80M against cash reserves of $175.42M. Kestra Medical Technologies' valuation metrics indicate significant deviations from industry norms. With a forward P/E ratio of -11.29, the company's stock price is currently below earnings per share, suggesting an inverted valuation relationship. The price to book ratio stands at 7.66 and the price to sales ratio at 19.19. Revenue growth (YoY) has been positive at 53.4%, but a lack of available data on earnings growth (YoY) hinders a comprehensive assessment of long-term financial performance.